FESARIUSTHERAPEUTICS INC ANNOUNCES FDA 510(K) CLEARANCE FOR DERMISPHERE HYDROGEL DERMAL REGENERATION TEMPLATE

Posted on by

NEW YORK, Jan. 8, 2025 /PRNewswire/ — FesariusTherapeutics Inc, an emerging bioregenerative technology company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care, Reconstructive Surgery and Regenerative Medicine markets, is pleased to…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.